NCT07396987Recruiting
Boosting Referrals to Asthma Specialists for Patients Seen at the Emergency Room for an Asthma Exacerbation
Source: ClinicalTrials.gov · Last updated 14 Sept 2026
Brief summary (registry, in English)
This study is testing a new way to help adults with asthma get follow up care after an emergency room (ER) visit for an asthma attack. Many people who come to the ER for asthma never see an asthma specialist afterward, even though specialists can offer treatments such as advanced inhalers or biologic medicines that may prevent future attacks. The study will compare two approaches. One group will receive a telehealth appointment with an asthma specialist that is scheduled for them before they leave the ER. The other group will receive the usual care, which typically includes a standard referral but no scheduled appointment. All participants will be offered a prescription for standard controller medication at discharge. The main question the study aims to answer is whether arranging a telehealth visit directly from the ER increases the number of patients who complete a follow up appointment with an asthma specialist within three months. The study will also look at whether this approach improves asthma control, reduces repeat ER visits, and helps patients better understand and use their asthma medications. This research may help identify a practical way to improve access to asthma specialists and reduce the burden of asthma for patients who frequently rely on emergency care.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 30 Jan 2026
- Start date
- 19 Jul 2026
- Primary completion date
- Jul 2027
- Lead sponsor
- Juan Carlos Cardet
- Diseases
- Asthma
- NCT number
- NCT07396987
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 19 Jul 2026 to the primary completion date, Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diagnosis of other pulmonary diseases (e.g., COPD, interstitial lung disease, etc.)
- We will allow for current smokers, vapers and cannabis users as long as they meet one of the COPD-allowable pathways below.
- COPD-allowable pathways:
- If none of the below are satisfied, then exclude for COPD.
- Documentation: PFTs must be within 36 months of enrollment date; smoking history must be calculated and entered in this form based on patient input. Pack- year history will be collected for characterization/analysis but will not determineeligibility.
- We will allow for COPD as long as they are:
Other
- Patients who have seen an asthma specialist (allergist or pulmonologist) for asthma in the past 1 year
- never smokers/vapers/cannabis users;
- former or current smokers/vapers/cannabis users with normal PFTs with FEV1/FVC \>=70% documented in a medical record within 36 months of the enrollment date
- former or current smoker/vapers/cannabis users with obstruction noted on PFTs (i.e., FEV1/FVC \<70%) but who demonstrates BOTH acute bronchodilator reversibility (i.e., \>10% increase in either FEV1%predicted or FVC% predicted) AND have a normal diffusing capacity (DLCO)
Who the study is looking for
- Age ≥18 years
- Asthma diagnosis ≥1 year
- Seen in ER for asthma exacerbation
- Persistent asthma on controller therapy
- ≥1 asthma exacerbation in prior year
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tampa General Hospital Emergency Room Coordinator of this site? Confirm its status | Tampa | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.